Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Stay ahead with 2024 windfall strategies that optimize payment timing, debt prioritization, and milestone tracking.
11,891 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A surprise turn in inflation and consumer confidence tests the nerves of investors. This guide explains what happens ...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
Markets moved to risk-off trading after Xi warned of a possible clash with the United States over Taiwan, hours befor...
Nvidia stock hits highs, renewing the debate over whether now is the moment to buy. This guide breaks down what's dri...
Investors are focused on figma (FIG) 2026 earnings as the company navigates growth and profitability. This guide brea...
Discover what the AENT 2026 earnings transcript reveals about growth, margins, and cash flow. This guide translates t...
Bitcoin slumped to a two-week low, dragging a wide swath of altcoins lower as risk-off trading returned this weekend....
A new analysis reveals that private equity inside 401(K) plans can charge 2%-3% annually, creating a long-term drag t...
Is Block stock a smart addition to your portfolio today? This guide ties Block's potential to tax advantaged investin...
Insider stock moves can tell a story, but one sale isn’t the whole chapter. This guide breaks down what a merit medic...
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...